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ABSTRACT
Objectives: Urinary tract infection (UTI) is one of the diseases with a highest prevalence in the world. This study evaluated the antibiotics resistant 
and the prescription pattern for UTI with the aim to participate as an effective monitoring study that enhances rational antibiotics’ prescription.
Methods: We conducted a retrospective cross-sectional study at King Fahad Specialist Hospital from May 2018 to January 2019. We included a total 
of 306 patients with UTI. 204 patients diagnosed clinically and empirically treated (Group A), 102 patients underwent urine for culture and sensitivity 
tests (Group B).
Results: UTI showed higher occurrence in female in both Groups A (61%) and B (65%). The mean age was higher in Group B (55.8 years) than Group A 
(39.44 years). The most commonly prescribed antibiotics for UTI were Trimethoprim + Sulfamethoxazole (TMP+SMX) (56%) and ciprofloxacin 
(15%). Escherichia coli was the most commonly isolated organism (36.3%) followed by Klebsiella pneumonia (30%). Although 41.17% of organisms 
were sensitive to TMP+SMX, 38.2% were resistant to it. The organisms were sensitive to amikacin in 80.4% and to gentamicin in 61.8% whereas, 
61.8% were resistant to ampicillin. Luckily, no resistance was reported neither for nitrofurantoin nor for vancomycin.
Conclusion: The study showed significant resistance to the commonly prescribed TMP+SMX and ciprofloxacin compared to absolute sensitivity to the 
less prescribed nitrofurantoin. This necessitates special consideration for local susceptibility in empirical therapy.
Keywords: Antibiotic, Prescription, Resistance, Urinary tract infection.
INTRODUCTION
Urinary tract infection (UTI) is one of the diseases with a highest 
prevalence in the world. It commonly affects female than male and 
more than 50% of all women were affected with UTI during their 
lifetime [1,2]. UTI is commonly bacterial in origin and mainly caused 
by Gram-negative bacteria, especially Escherichia coli. Other causative 
bacteria include Klebsiella pneumonia, Proteus mirabilis, Pseudomonas 
aeruginosa, Enterobacter species, Enterococcus species, Group B 
Streptococcus, and Staphylococcus saprophyticus [3,4].
UTI can easily be treated with different regimens of antibiotics with 
varying efficacy, tolerability, and cost. The treatment is commonly 
started before the culture and susceptibility test results [5]. 
However, the massive and inappropriate use of antibiotics has led to 
increased antimicrobial resistance that strongly necessitates knowledge 
about antimicrobial susceptibility pattern. This study evaluated and 
compared the antibiotic susceptibility pattern to prescription pattern 
in patients with UTI attending at King Fahad Specialist Hospital.
METHODS
A retrospective cross-sectional, hospital-based study was conducted 
at King Fahad Specialist Hospital in the period from May 2018 to 
January 2019. The study was approved by the Regional Research 
Ethics Committee-Qassim Province, under the registration number 
1441-524299. We included a total of 306 UTI patients in this study. 
We categorized them into two groups; 204 patients were clinically 
diagnosed with UTI and empirically treated with antibiotics (Group A), 
the remaining 102 patients were diagnosed based on urine culture 
and sensitivity tests (Group B). The urine specimens after processing 
were incubated at a temperature of 35 ± 2°C on CLED agar for 24–48 h. 
The isolates of bacterial colony were identified and a count ≥100,000 
colony-forming units per milliliter of urine was considered positive. The 
antimicrobial susceptibility was determined using the disk diffusion 
method. We constructed two data collection forms; one designed 
for Group (A) and it included patients’ demographic characteristics, 
the diagnosis, the antibiotics prescribed, their doses, frequency, and 
duration. The other was designed for Group (B) and it included patients’ 
demographic characteristics, the type of bacteria that were isolated, the 
antibiotics sensitivity, and resistance results. The data were analyzed by 
Statistical Package for the Social Sciences (SPSS) version 23. We used 
descriptive statistics for the analysis of demographic data of patients, 
antibiotics prescription, bacteria isolated, and the sensitivity and 
resistance patterns of organisms to antibiotics. Chi-squared test was 
used for the association among categorical variables and p>0.05 was 
considered significant.
RESULTS
The demographic characteristics of the study population
UTI was common (62.1%) in female in both studied groups representing 
(60.8%) in Group A and (64.7%) in Group B. In Group A, the UTI was 
higher in age group 19–36 years (47.5%, n=97) with a mean age of 
38.9 year, while in Group (B), the UTI was higher among age group 
of 55–72 years (43.1%, n=44) with a mean age of 55.83 year. In both 
groups, UTI was less in patients aged 1–18 years (5.5%) and in those 
more than 72 years (8.8%). The disease was mainly distributed among 
patients aged 19–72 years (Table 1).
The pattern of antibiotics prescription
A total of 224 antibiotics were empirically prescribed for 204 patients. 
Trimethoprim + Sulfamethoxazole (TMP+SMX) was the most commonly 
prescribed antibiotics (56%, n=126) in a dose of 960 mg and a mean 
duration of 5.1 days then followed by ciprofloxacin (15%, n=33) in a 
dose of 500 mg with mean duration of 6.2 days and cefuroxime axetil 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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The antibiotics’ sensitivity and resistance pattern
The findings in the urine culture and sensitivity tests of Group B patients 
showed that E. coli was the most commonly isolated organism (36.3%, 
n=37), followed by K. pneumonia (29.4%, n=30), Enterococcus faecalis 
(10.8%, n=11), and P. aeruginosa (8.8%, n=9) while Streptococcus, 
Providencia spp., and Staphylococcus aureus were the least isolated 
organisms. There was significant association between the type of 
organisms isolated and the gender as p=0.029 (Table 3). An 80.4% of the 
organisms isolated were sensitive to amikacin, followed by meropenem 
(79.4%), imipenem (78.4%), and gentamicin (61.8%). While, the 
resistant to ampicillin was detected in 61.8%, followed by ciprofloxacin 
(48%) and only 1% resistance to tigecycline was reported. Although, 
41.2% of the organisms were sensitivity to TMP+SMX, 38.2% of them 
were resistant to it. Intermediated sensitivity was seen in gentamicin 
(5.9%), ciprofloxacin (4.9%), tigecycline (4.9%), cefuroxime (3.9%), 
imipenem (2.9%), and amikacin (2%). No resistance was reported 
neither for nitrofurantoin nor for vancomycin in the tested patients 
(Table 4).
DISCUSSION
This cross-sectional, hospital-based study showed that UTI was more 
common (62.1%) in female in both studied Groups A and B. UTI still 
higher in female until the age group 55–72 years (14.4% in female and 
8.1% in male); however, it was more in male than female in patients 
aged more than 72 years. In study done by Salem et al. reported more 
occurrence of UTIs in female (67.6%) than in male (32.4%) [6]. Foxman 
also reported that the prevalence of UTI is higher in women than men 
Table 3: The organisms isolated in urine culture correlated with 
gender (n=102)





Escherichia coli 8.8 (9) 27.5 (28) 36.3 (37)
Providencia spp. 0 (0) 1 (1) 1 (1)
Klebsiella pneumonia 7.8 (8) 21.6 (22) 29.4 (30)
Pseudomonas aeruginosa 6.9 (7) 2 (2) 8.8 (9)
Enterococcus faecalis 4.9 (5) 5.9 (6) 10.8 (11)
Staphylococcus aureus 1 (1) 0 (0) 1 (1)
Staphylococcus epidermidis 2 (2) 0 (0) 2 (2)
Enterobacter aerogenes 0 (0) 2 (2) 2 (2)
Enterobacter cloacae 2 (2) 2 (2) 3.9 (4)
Proteus mirabilis 1 (1) 2.9 (3) 3.9 (4)
Streptococcus 1 (1) 0 (0) 1 (1)
Total 35.3 (36) 64.7 (66) 100 (102)
p-value=0.029 <0.05 we accept the null hypothesis at alpha=0.05. 
Hence, there is association between the type of organisms and 
gender at significant level 0.05
(11%, n=24) while the least frequency was observed in cefepime (0.4%, 
n=1) (Table 2). In most of the patients (90.2%), only one antibiotic was 
empirically prescribed for the treatment of UTI and in few cases (9.3%) 
two antibiotics were prescribed and only one patient received three 
types of antibiotics (0.5%).
Table 1: Age and gender distribution of urinary tract infections’ patients (n=306)
Age groups Group (A) Group (B) Total Group A and B
Gender Total % 
(n)
Gender Total % 
(n)
Gender Total % (n)
Male % (n) Female % (n) Male % (n) Female % (n) Male % (n) Female % (n)
1–18 years 1.9 (4) 4.4 (9) 6.4 (13) 1.9 (2) 1.9 (2) 3.9 (4) 1.9 (6) 3.6 (11) 5.5 (17)
19–36 years 20 (41) 27.4 (56) 47.5 (97) 2.9 (3) 13.7 (14) 16.7 (17) 14.4 (44) 22.9 (70) 37.3 (114)
The antibiotics prescribed Frequency % (n) Dose in mg (frequency) Mean of duration (days)
TMP-SMX* 56 (126) 960 mg (126) 5.1
Ciprofloxacin 15 (33) 500 mg (29)
250 mg (4)
6.2
Cefuroxime axetil 11 (24) 500 mg (20)
250 mg (4)
5.5
Amoxicillin clavulanic acid 4 (9) 1000 mg (5) 
625 mg (4)
6
Amoxicillin 2 (4) 500 mg (3) 
250 mg (1)
5
Levofloxacin 1 (2) 750 mg (1)
250 mg (1)
12
Nitrofurantoin 1.3 (3) 100 mg (3) 7
Ceftriaxone 4 (10) 2000 mg (5)
1000 mg (5)
3.5
Doxycycline 1 (2) 100 mg (2) 10
Metronidazole 1 (3) 500 mg (3) 5
Tazocin 1 (2) 2250 mg (1)
4500 mg (1)
3
Cefepime 0.4 (1) 1000 mg (1) 7
Azithromycin 2 (5) 500 mg (3)
1000 mg (2)
3
Total 100.0 (224) - -
*TMP/SMX: Trimethoprim/sulfamethoxazole
37–54 years 8.3 (17) 19.1 (39) 27.4 (56) 8.8 (9) 13.7 (14) 22.5 (23) 8.5 (26) 17.3 (53) 25.8 (79)
55–72 years 3.9 (8) 8.3 (17) 12.3 (25) 16.7 (17) 26.5 (27) 43.1 (44) 8.1 (25) 14.4 (44) 22.5 (69)
>72 years 4.9 (10) 1.5 (3) 6.4 (13) 4.9 (5) 8.8 (9) 13.7 (14) 4.9 (15) 3.9 (12) 8.8 (27)
Total 39.2 (80) 60.8 (124) 100 (204) 35.3 (36) 64.7 (66) 100 (102) 37.9 (116) 62.1 (190) 100 (306)
Table 2: The antibiotics prescribed for urinary tract infection (n=204)
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and it still higher even at the age of 60 years [7]. Furthermore, Keyhan 
et al. reported a higher incidence of UTIs in patients aged 36–65 years 
in female, while in male it was most frequency in age <65 years old [8].
In this study, we noticed that among patients in Group A the UTI was 
common (47.5%) in young adult (19–36 years) with a mean age of 38.9 
years, while in Group B it was common (43.1%) among the elderly (55–72 
years) with a mean age of 55.8 years, reflecting the possibility of resistance 
and high recurrence rate at this age group which justify the need for 
culture and sensitivity tests. In general, in both studied groups, there was 
less occurrence of UTIs at the extremities of age; in younger aged patients 
(1–18 years) (5.5%) and patients more than 72 years (8.8%).
In this study, sulfamethoxazole+ trimethoprim (960 mg) twice daily was 
the most antibiotic prescribed as empirical antibiotics (56%), followed 
by ciprofloxacin (15%), cefuroxime axetil (11%), amoxicillin clavulanic 
acid (4%), and ceftriaxone (4%). Inversely, we noticed a different result 
reported by Mohamed et al. as they found that the most antibiotics 
prescribed empirically were amoxicillin (28%), followed by ciprofloxacin 
(11%), and co-amoxiclav (10%). As reported in international survey on 
the antimicrobial resistance of microorganisms causing UTI, there is a 
wide variability across countries in bacterial susceptibility rates to the 
antimicrobials [9], so the empirical antibiotic therapy should consider 
the local susceptibility patterns of uropathogens.
This study showed that most of physician prescribed only one type of 
antibiotic (n=184, 90.2%) for the treatment of UTI. There are only few 
cases where two antibiotics were prescribed (n=18, 9.3%) and only one 
patient received three types of antibiotics (0.5%). These findings largely 
agreed with the guideline for empirical treatment of UTIs [10,11].
In Group B patients, the urine culture results showed that E. coli 
was the most commonly isolated organism (36.3%), followed by 
K. pneumonia (29.4%), E. faecalis (10.8%), P. aeruginosa (8.8%), and 
P. mirabilis (3.9%), while, Streptococcus (1%), providencia spp. (1%), 
and staphylococcus aureus (1%) were the least. In study done by Cunha 
et al., showed a highest frequency of E. coli (60.4%) and followed by 
Klebsiella spp. (14.2%) (3). Furthermore, Wong et al. study found out 
that the most common pathogen isolated was E. coli (75.9%) [12].
We compared the type of organism isolated with the patients’ age and 
gender and we concluded that there was no association with age as 
p=0.17. In contrast, there was significant association with gender as 
p=0.029 and we consider p value significant at <0.05.
In Group B patients, the organisms isolated were highly sensitive 
to amikacin (80.4%), followed by meropenem (79.4%), imipenem 
(78.4), and gentamicin (61.8%), while TMP/SMX although it showed 
(41.2%) sensitivity, the resistance was significantly high (38.2%). 
Luckily, the organisms were found to be absolute sensitive and no 
reported resistance in all tested cases for nitrofurantoin (10 cases) 
and vancomycin (14 cases). The organisms were highly resistant to 
ampicillin (61.8%), followed by ciprofloxacin (48%), piperacillin 
(42%), and less resistance to tigecycline (1%); however, there was 
intermediated effect to gentamicin (5.9%). We observed that there is 
a significant resistance among the commonly empirically prescribed 
antibiotics (TMP/SMX and ciprofloxacin) while no reported resistance 
among the less prescribed one (nitrofurantoin) which reflects overuse 
among empirical prescription of antibiotics and necessitate special 
consideration for local susceptibility patterns when prescribing the 
antibiotics empirically for UTI patients. In Cunha et al. study, they 
found that aminoglycosides, nitrofurantoin, and third-generation 
cephalosporins were highly susceptible over (90%) while TMP-SMX 
and quinolones reported highly resistance [3].
CONCLUSION
The study of UTI at KFSH showed UTIs pattern aligned with international 
studies as UTI was most common in female and commonly caused 
by E. coli. However, significant resistance to the highly empirically 
prescribed TMP+SMX and ciprofloxacin was noted, beside absolute 
sensitivity to nitrofurantoin which should be considered in the 
empirical therapy for UTI with regard to the local susceptibility pattern.
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Table 4: The antibiotics sensitivity and resistance patterns in isolated organisms
Antibiotics tested Sensitive % (n) Resistant % (n) Intermediate % (n) Not tested % (n)
Ampicillin 22.5 (23) 61.8 (63) 0 (0) 15.7 (16)
Cefuroxime 31.4 (32) 40.2 (41) 3.9 (4) 24.5 (25)
Ceftazidime 43.1 (44) 42.2 (43) 0 (0) 14.7 (15)
Gentamicin 61.8 (63) 18.6 (19) 5.9 (6) 13.7 (14)
Amikacin 80.4 (82) 2.9 (3) 2.0 (2) 14.7 (15)
Imipenem 78.4 (80) 2.9 (3) 2.9 (3) 15.7 (16)
Meropenem 79.4 (81) 4.9 (5) 0 (0) 15.7 (16)
Piperacillin 33.3 (34) 42.2 (43) 0 (0) 24.5 (25)
Cefepime 42.2 (43) 41.2 (42) 0 (0) 16.7 (17)
Tazocin 33.3 (34) 23.5 (24) 1 (1) 42.5 (43)
TMP-SMX * 41.2 (42) 38.2 (39) 0 (0) 20.6 (21)
Tetracycline 30.4 (31) 36.3 (37) 0 (0) 33.3 (34)
Amoxicillin + clavulanate 32.4 (33) 42.2 (43) 2.9 (3) 22.5 (23)
Ciprofloxacin 45.1 (46) 48 (49) 4.9 (5) 2 (2)
Cefotaxime 33.3 (34) 38.2 (39) 0 (0) 28.4 (29)
Tigecycline 56.9 (58) 1 (1) 4.9 (5) 37.3 (38)
Nitrofurantoin 9.8 (10) 0 (0) 0 (0) 90.2 (92)
Vancomycin 13.7 (14) 0 (0) 0 (0) 86.3 (88)
*TMP/SMX: Trimethoprim/sulfamethoxazole
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